COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 119: Articles 1181-1190  | Next

Adjusting for specificity of symptoms reveals higher prevalence of asymptomatic SARS-CoV-2 infections than previously estimated
Tiwari, A., Chowdhury, S., James, A., Chatterjee, B., Dixit, N. M.
10.1101/2024.09.11.24313462 — Posted: 2024-09-12
Assessing the Impact of Haulage drivers in Uganda's COVID-19 Delta Wave
Muwonge, A., Bessell, P. R., Bronsvoort, B. M. d. C., Mugerwa, I., Mwaka, E., Ssebaggala, E., Bryan, W. A., Kiayias, A., Mpyangu, C. M., Joloba, M. L.
10.1101/2024.09.10.24313441 — Posted: 2024-09-12
Protection of vaccine boosters and prior infection against mild/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024
Kirwan, P. D., Foulkes, S. D., Munro, K., Sparkes, D., Singh, J., Henry, A., Dunne, A., Timeyin, J., Russell, S., Khawam, J., Blick, D., Otter, A. D., Hettiarachchi, N., Cairns, M., Jackson, C. H., Seaman, S., Brown, C. S., SIREN Study Group, , Atti, A., Islam, J., Charlett, A., De Angelis, D., Presanis, A. M., Hall, V. J., Hopkins, S.
10.1101/2024.09.11.24313477 — Posted: 2024-09-12
Electromagnetic waves destabilize the SARS-CoV-2 Spike protein and reduce SARS-CoV-2 Virus-Like Particle (SC2-VLP) infectivity
Granatir, S., Acosta, F. M., Pantoja, C., Tailor, J., Fuori, A., Dower, B., Marr, H., Ramirez, P. W.
10.1101/2024.09.11.612487 — Posted: 2024-09-12
Inhibition of HIF-2α Pathway as a Potential Therapeutic Strategy for Endothelial Dysfunction in Post-COVID Syndrome
Kuchler, T., Ribeiro, A., Lech, M., Carbajo-Lozoya, J., Adorjan, K., Stubbe, H. C., Seifert, M., Wöhnle, A., Kessler, V., Negele, J., Heemann, U., Schmaderer, C.
10.1101/2024.09.10.24313403 — Posted: 2024-09-11
Dutch participatory surveillance framework for evaluating evolutionary changes on SARS-CoV-2 affecting Rapid Diagnostic Test sensitivity in 2022 - 2023.
Kozanli, E., Han, W., Smit, T., de Bakker, J., Elahi, M., Jaarsma, R., Carstens, G., van Hoek, A. J., Eggink, D.
10.1101/2024.09.10.24313404 — Posted: 2024-09-10
5-hydroxymethylcytosine Epigenetic Markers in COVID-19-Associated Acute Coronary Syndrome: Insights into Neutrophil Activation and PDE4D Upregulation
Li, Z., Duolikun, M., Chen, H., Zhang, L., Liu, Y., Li, R., Li, D., Chen, L., sun, l.
10.1101/2024.09.09.24313367 — Posted: 2024-09-10
Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022/2023 respiratory season in the Netherlands
Carstens, G., Kozanli, E., Bulsink, K., McDonald, S., Elahi, M., de Bakker, J., Schipper, M., van Gageldonk-Lafeber, R., van den Hof, S., van Hoek, A. J., Eggink, D.
10.1101/2024.09.10.24313400 — Posted: 2024-09-10
The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops is Determined by Ligand Binding and Interprotomer Allostery
Lee, E., Rauscher, S.
10.1101/2024.09.09.612101 — Posted: 2024-09-10
Reversible Transcriptomic Age Shifts from Physiological Stress in Whole Blood
Bhak, J., Nam, D., An, K., Kwon, Y., Bhak, J., Jeon, S., Ryu, H.
10.1101/2024.09.08.611853 — Posted: 2024-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).